BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24972251)

  • 1. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
    Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte Crossmatch Testing or Donor HLA-DP and -DQ Allele Typing Effectiveness in Single Cord Blood Transplantation for Patients With Anti-HLA Antibodies Other Than Against HLA-A, -B, -C, and -DRB1.
    Osada M; Yamamoto H; Watanabe O; Yamaguchi K; Kageyama K; Kaji D; Taya Y; Nishida A; Ishiwata K; Takagi S; Makino S; Asano-Mori Y; Yamamoto G; Taniguchi S; Wake A; Uchida N
    Transplant Cell Ther; 2024 Apr; ():. PubMed ID: 38641011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantation.
    Jo T; Arai Y; Hatanaka K; Ishii H; Ono A; Matsuyama N; Mori J; Koh Y; Azuma F; Kimura T
    Cytotherapy; 2023 Apr; 25(4):407-414. PubMed ID: 36335019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.
    Dahi PB; Barone J; Devlin SM; Byam C; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Hsu SH; Barker JN
    Biol Blood Marrow Transplant; 2014 May; 20(5):735-9. PubMed ID: 24462980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
    Sanz J; Jaramillo FJ; Planelles D; Montesinos P; Lorenzo I; Moscardó F; Martin G; López F; Martínez J; Jarque I; de la Rubia J; Larrea L; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):106-10. PubMed ID: 24516896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
    Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The impact of HLA matching on outcome of single unit unrelated cord blood transplantation: a retrospective single center clinical analysis].
    Sun G; Sun Z; Liu H; Zheng C; Tang B; Zhu X; Song K
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):678-83. PubMed ID: 25152111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial.
    Mevorach D; Zuckerman T; Reiner I; Shimoni A; Samuel S; Nagler A; Rowe JM; Or R
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):58-65. PubMed ID: 24140121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).
    Cornetta K; Laughlin M; Carter S; Wall D; Weinthal J; Delaney C; Wagner J; Sweetman R; McCarthy P; Chao N
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):149-60. PubMed ID: 15682076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
    Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
    Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation.
    Ho VT; Kim HT; Liney D; Milford E; Gribben J; Cutler C; Lee SJ; Antin JH; Soiffer RJ; Alyea EP
    Bone Marrow Transplant; 2006 May; 37(9):845-50. PubMed ID: 16532020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.
    Passweg JR; Schanz U; Chalandon Y; Güngör T; Baldomero H; Heim D; Nair G; Medinger M; Masouridi-Levrat S; de Faveri GN; Tiercy JM;
    Bone Marrow Transplant; 2015 Sep; 50(9):1201-5. PubMed ID: 26052916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia.
    Atsuta Y; Morishima Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kobayashi N; Fukuda T; Azuma H; Takanashi M; Mori T; Tsuchida M; Kawase T; Kawa K; Kodera Y; Kato S;
    Biol Blood Marrow Transplant; 2012 May; 18(5):780-7. PubMed ID: 22008851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.
    Mori T; Tanaka M; Kobayashi T; Ohashi K; Fujisawa S; Yokota A; Fujita H; Nakaseko C; Sakura T; Nannya Y; Takahashi S; Kanamori H; Kanda Y; Sakamaki H; Okamoto S;
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):486-91. PubMed ID: 23253560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders.
    Kwon M; Balsalobre P; Serrano D; Pérez Corral A; Buño I; Anguita J; Gayoso J; Diez-Martin JL
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):143-9. PubMed ID: 22960386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.